FSHD Global was pleased to join Muscular Dystrophy Queensland for a webinar covering the latest developments in FSHD research and the Clinical Trial Passport, including what’s on the horizon for the community.
Our Managing Director, Emma Weatherley, presented alongside a range of speakers from across the neuromuscular sector. Watch the session below:
If you would like to watch all of the sessions from the webinar, the full playlist is available on YouTube here.